The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden ...
Danish pharmaceutical company Novo Nordisk plans to introduce its weight-loss drug Wegovy in India earlier than planned to ...
Doctors say it’s not uncommon for patients to not lose weight on the GLP-1 drugs, even if celebrities are seemingly shedding dozens of pounds. Julia Musto spoke to people frustrated that they are part ...
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...
CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they ...
Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular ...
By Puyaan Singh (Reuters) - The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a ...
To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...
The Canadian Press on MSN1d
Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, MounjaroA Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...
The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback